Bladder Cancer,Genitourinary Cancer DNA Aneuploidy Predicts Pembrolizumab Response in Metastatic Urothelial Cancer Patients Nov 22, 2023
Bladder Cancer,Genitourinary Cancer EV+P Improves Outcomes Over Chemo In Previously Untreated la/mUC Nov 08, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) 89Zr-DFO-girentuximab PET/CT Found Effective In Identifying And Characterizing IDRMs Nov 07, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Finding The Optimal Approach For Managing Oligometastatic Renal Cancer Nov 07, 2023
Genitourinary Cancer,Prostate Cancer High 18F-rhPSMA-7.3 Detection Rates Observed In Patients With Recurring Prostate Cancer Nov 06, 2023
Genitourinary Cancer,Prostate Cancer Optimal Procedures for [177Lu]Lu-PSMA-617 Therapy in US Prostate Cancer Centers Nov 06, 2023
Genitourinary Cancer,Prostate Cancer Enzalutamide Plus ADT Improve Outcomes In mHSPC Irrespective Of Baseline PSA Levels Nov 03, 2023
